Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (7727)	1/15/2003 11:45:13 AM
From: Biomaven	Respond to of 52153

A set of resources and statistics at the FDA: Drug Firm Annual Registration Status fda.gov News Along the Pike: Special Edition: Jim Morrison's Ombudsman's Corners Drug Approval Reports fda.gov Approval Times for Priority and Standard NMEs - Calendar Years 1993-2001 fda.gov Approval Times for Priority and Standard NDAs - Calendar Years 1993-2002 fda.gov Efficacy Supplements Approved in Calendar Year 2002 fda.gov NDA Approvals for Calendar Year 2002 fda.gov NDAs Approved in Calendar Years 1990-2002 by Therapeutic Potential and Chemical Types fda.gov NDAs Approved under Subpart H fda.gov NDA and NDA Supplements Approved under Subpart H fda.gov Tentative Advisory Committee Meetings, CDER fda.gov January 13, 2003 FDA releases preliminary survey results on direct-to-consumer prescription drug ads. FDA Talk Paper fda.gov Investigational Human Drugs: Clinical Investigator Inspection List fda.gov New and Generic Drug Approvals [Includes Drug Label and Approval Letter] fda.gov Peter